Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chang Chun Petrochemical (CCPC) is a leading global manufacturer of specialty chemicals and a core member of the Taiwan-based Chang Chun Group. The company produces a vast array of chemical products, including polyvinyl alcohol (PVA), acetic acid, epichlorohydrin, and high-purity electronic chemicals. Within the life sciences and healthcare sectors, CCPC is a critical supplier of pharmaceutical-grade excipients, chemical intermediates, and advanced materials used in medical device manufacturing and healthcare packaging. The company is particularly recognized as one of the world's largest producers of PVA, which is widely utilized in ophthalmic solutions and tablet coatings. CCPC operates large-scale, sophisticated manufacturing facilities that adhere to rigorous international quality and safety standards. Its products serve as foundational components for various medical and pharmaceutical applications globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chang Chun Petrochemical.